Testing effectiveness (Phase 2)Ended earlyNCT01795976What this trial is testingNY-ESO-1 T Cells in OG CancerWho this might be right forOesophageal Cancer Fiona Thistlethwaite 2
Early research (Phase 1)Study completedNCT00252889What this trial is testingDoxil Topotecan Doublet Cancer StudyWho this might be right forSmall Cell Lung CancerPancreatic CancerHead and Neck Cancer+2 more Christiana Care Health Services 20
Testing effectiveness (Phase 2)Looking for participantsNCT06747585What this trial is testingInvestigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid TumorsWho this might be right forSquamous Non-small-cell Lung CancerHead and Neck Squamous Cell CarcinomaCervical Squamous Cell Carcinoma+1 more Alentis Therapeutics AG 170
Large-scale testing (Phase 3)Not Yet RecruitingNCT05244798What this trial is testingSintilimab Plus NCT or NCRT Versus NCRT for ESCCWho this might be right forEsophageal Squamous Cell Carcinoma Sichuan Cancer Hospital and Research Institute 420
Testing effectiveness (Phase 2)Looking for participantsNCT07733830What this trial is testingComparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCCWho this might be right forEsophageal Cancer Tianjin Medical University Cancer Institute and Hospital 120
Testing effectiveness (Phase 2)Ended earlyNCT00064259What this trial is testingA Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction CancerWho this might be right forAdenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+11 more National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Ended earlyNCT00423150What this trial is testingPhase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED)Who this might be right forColorectal NeoplasmHead and Neck NeoplasmCarcinoma, Non-Small-Cell Lung+1 more Merck Sharp & Dohme LLC 86
Testing effectiveness (Phase 2)Study completedNCT00719550What this trial is testingAMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction CancerWho this might be right forEsophagogastric Junction AdenocarcinomaGastric CancerEsophageal Cancer Amgen 130
Testing effectiveness (Phase 2)Study completedNCT00003055What this trial is testingCisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric CancerWho this might be right forEsophageal CancerGastric Cancer Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)UnknownNCT01523015What this trial is testingEfficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric JunctionWho this might be right forAdenocarcinoma of the Gastroesophageal Junction Medical University of Lublin 100
Testing effectiveness (Phase 2)UnknownNCT00915850What this trial is testingTrial of Docetaxel, Cisplatin, Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC)Who this might be right forEsophageal Cancer Wakayama Medical University 32
Testing effectiveness (Phase 2)Study completedNCT03322267What this trial is testingAdjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of RecurrenceWho this might be right forEsophageal Squamous Cell Carcinoma National Taiwan University Hospital 26
Testing effectiveness (Phase 2)Study completedNCT00002984What this trial is testingCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the EsophagusWho this might be right forEsophageal Cancer UNC Lineberger Comprehensive Cancer Center 26
Early research (Phase 1)Not Yet RecruitingNCT07583316What this trial is testingFirst-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid TumorsWho this might be right forLung Cancer (Locally Advanced or Metastatic)Esophagus CancerHead and Neck Cancer+1 more Corregene Biotechnology Co., Ltd 192
Testing effectiveness (Phase 2)Study completedNCT03925870What this trial is testingKN046 in Subjects With Late Stage Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma Jiangsu Alphamab Biopharmaceuticals Co., Ltd 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06374888What this trial is testingNilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain MetastasesWho this might be right forHer2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastasis Convalife (Shanghai) Co., Ltd. 28
Testing effectiveness (Phase 2)Looking for participantsNCT07749586What this trial is testingEvaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor Arvinas Inc. 499
Not applicableActive Not RecruitingNCT06504615What this trial is testingObservational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in FranceWho this might be right forGastric AdenocarcinomaGastro-esophageal Junction AdenocarcinomaEsophageal Adenocarcinoma (EAC)+1 more Bristol-Myers Squibb 208
Early research (Phase 1)Looking for participantsNCT06773507What this trial is testingPhase I Study of BC008-1A Injection in Patients With Advanced Solid TumorsWho this might be right forAdvanced Esophageal CancersAdvanced Non-small Cell Lung Cancer (NSCLC) Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. 80
Early research (Phase 1)Looking for participantsNCT06065371What this trial is testingSacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard TherapyWho this might be right forGastrointestinal Cancer Henry Ford Health System 20